Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...

In BlueAllele Corp. v. Intellia Therapeutics, Inc., 2024 U.S. Dist. Lexis 222094 (D. Del. Dec. 9, 2024)1, the District of ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on MaxCyte (MXCT – Research Report) today. The company’s shares opened today at ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

The Colossal Foundation, the 501(c)(3) arm of Colossal BioSciences and a leading organization focused on pioneering ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

The best defense is a good offense. US agricultural exporters need to go on the offensive and urge the Trump administration to support their push for science-based SPS measures and transparent ...

A joint research team has developed a biotemplating method that utilizes specific internal proteins in biological samples and ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...